I

Immunomic Therapeutics, Inc.

42 employees

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.

Basic info

biotechnology research

DNA Vaccines

Biotechnology

Allergy

LAMP Technology

Therapeutics

Oncology

Infectious Diseases

Animal Health

Life Science

2005

$3M

from 4 investors over 4 rounds

I

Immunomic Therapeutics, Inc. raised undisclosed on November 1, 2015

Investors: Keiretsu Forum Northwest

I

Immunomic Therapeutics, Inc. raised $3M on October 17, 2013

Investors: Mid Atlantic Bio Angels

I

Immunomic Therapeutics, Inc. raised $600K on March 28, 2010

Investors: Brainchild & Co. and LSGPA: The Life Sciences Greenhouse of Central PA